In the interim analysis , time to first relapse was significantly different in favor of the paliperidone palmitate group vs the placebo group ( hazard ratio = @ ; @ % CI , @-@ @ ; P < @ ) ; median time to relapse was @ days for placebo but not estimable for @-month paliperidone palmitate .